Immunoassay Biomarker Test Menu Expansion Global Market Report 2026

Description

Immunoassay biomarker test menu expansion refers to the process of broadening the range of biomarkers that can be detected and quantified using immunoassay techniques. It involves the development of new assays or the modification of existing ones to improve diagnostic capabilities and strengthen disease detection and monitoring. This expansion enables laboratories and healthcare providers to deliver more comprehensive testing solutions for accurate and timely clinical decision-making.

The primary types of immunoassay biomarker test menu expansion include enzyme-linked immunosorbent assay kits, chemiluminescent immunoassay kits, fluorescent immunoassay kits, multiplex immunoassay panels, rapid diagnostic test kits, biomarker-specific reagents, calibration standards, and quality control materials. Enzyme-linked immunosorbent assay kits refer to antibody-based detection systems used to detect and quantify specific biomarkers in biological samples for clinical and research applications. These involve various biomarker types such as oncology biomarkers, cardiac biomarkers, endocrine and hormonal biomarkers, infectious disease biomarkers, autoimmune disease biomarkers, neurological biomarkers, and therapeutic drug monitoring biomarkers, and they are categorized by grades including high performance liquid chromatography and ultra high performance liquid chromatography grade reagents, gas chromatography grade reagents, analytical grade reagents, liquid chromatography-mass spectrometry grade reagents, preparative grade reagents, biotechnology grade reagents, and technical grade filtration products. The various applications include clinical diagnostics, companion diagnostics, personalized medicine, and drug discovery and clinical research, and they are utilized by several end users such as pharmaceutical and biotechnology companies, contract research organizations, contract manufacturing organizations, academic and research institutions, clinical and diagnostic laboratories, food and beverage testing laboratories, environmental testing laboratories, government and regulatory agencies, and chemical and industrial manufacturing companies.

Tariffs are affecting the immunoassay biomarker test menu expansion market by raising the cost of imported reagents, assay kits, antibodies, and specialized diagnostic instruments used in laboratory testing. This is resulting in increased operational costs for clinical and research laboratories and slowing the adoption of advanced multiplex and biomarker-specific assays, particularly in import-dependent regions such as Asia-Pacific and Latin America. Segments including chemiluminescent immunoassay kits and biomarker-specific reagents are the most impacted due to their reliance on high-precision imported components. However, tariffs are also encouraging local reagent manufacturing, strengthening regional diagnostic supply chains, and accelerating domestic innovation in immunoassay technologies.

The immunoassay biomarker test menu expansion market research report is one of a series of new reports from The Business Research Company that provides immunoassay biomarker test menu expansion market statistics, including immunoassay biomarker test menu expansion industry global market size, regional shares, competitors with a immunoassay biomarker test menu expansion market share, detailed immunoassay biomarker test menu expansion market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay biomarker test menu expansion industry. This immunoassay biomarker test menu expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoassay biomarker test menu expansion market size has grown rapidly in recent years. It will grow from $0.53 billion in 2025 to $0.6 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing prevalence of chronic and infectious diseases, rising adoption of immunoassay based diagnostic technologies in clinical laboratories, expansion of hospital diagnostic infrastructure and lab networks, growing awareness of early disease detection and preventive healthcare, increasing government funding for diagnostic research and laboratory modernization.

The immunoassay biomarker test menu expansion market size is expected to see rapid growth in the next few years. It will grow to $0.95 billion by 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized biomarker profiling, increasing integration of AI and automation in diagnostic laboratories, expansion of companion diagnostics in drug development pipelines, growing adoption of multiplex and high throughput testing platforms, increasing focus on early cancer and chronic disease detection programs. Major trends in the forecast period include expansion of multiplex immunoassay panels for multi biomarker disease detection, increasing development of high sensitivity chemiluminescent immunoassay platforms, rising adoption of personalized medicine driven biomarker testing solutions, growing integration of automated laboratory immunoassay analyzers for high throughput testing, increasing demand for oncology and infectious disease biomarker assay expansion.

The increasing prevalence of chronic and lifestyle diseases is expected to propel the growth of the immunoassay biomarker test menu expansion market going forward. Chronic and lifestyle diseases are long-term health conditions such as heart disease, diabetes, obesity, and hypertension that persist over extended periods and require continuous medical care. The rising prevalence of these diseases is driven by aging populations and lifestyle-related risk factors such as poor dietary habits and physical inactivity, which are significantly contributing to the growing burden of chronic health conditions. Immunoassay biomarker test menu expansion supports enhanced disease detection by enabling laboratories to identify a broader range of disease-associated biomarkers, thereby improving early diagnosis, monitoring, and clinical decision-making. For instance, in April 2025, according to the US Centers for Disease Control and Prevention, a US-based government public health agency, in 2023, 76.4% of US adults reported at least one chronic condition, representing more than 194 million adults with ongoing health conditions that require regular monitoring and management. Therefore, the increasing prevalence of chronic and lifestyle diseases is expected to propel and support the growth of the immunoassay biomarker test menu expansion market.

Leading companies operating in the immunoassay biomarker test menu expansion market are focusing on developing advanced automated immunoassay panels, such as fully integrated immunoassay systems that streamline sample handling and result reporting within a single automated workflow, to reduce operator variability and increase laboratory throughput. Automated immunoassay panels are systems in which immunoassay tests are performed with minimal manual intervention through robotics or automated analyzers that manage sample preparation, reagent mixing, incubation, detection, and result output, improving consistency and turnaround time in clinical settings. For example, in May 2024, bioMerieux, a France-based healthcare technology company, launched the VIDA TBI (GFAP, UCH-L1) test for its automated immunoassay platforms VIDAS 3 and VIDAS KUBE, featuring high sensitivity for traumatic brain injury biomarkers, compatibility with on-demand automated workflows 24/7, and rapid result turnaround, aiding efficient clinical triage and reducing unnecessary imaging. The launch strengthens bioMerieux's immunoassay test menu by expanding its neurological biomarker portfolio and addressing growing demand for rapid diagnostic solutions in emergency care settings. Additionally, it supports improved clinical decision-making by enabling timely and accurate detection of brain injury, enhancing patient management, and optimizing healthcare resource utilization.

In July 2024, Roche, a Switzerland-based healthcare technology company, acquired LumiraDx's point-of-care technology business for an agreed purchase price of approximately $295 million plus up to $55 million in additional payments. With this acquisition, Roche aims to broaden its diagnostics portfolio by integrating a multi-assay point-of-care platform that combines immunoassay, clinical chemistry, and related tests, expanding access to decentralized diagnostic solutions and accelerating global testing capabilities in primary care. LumiraDx is a UK-based healthcare technology company specializing in an advanced point-of-care diagnostic platform capable of running a wide range of immunoassay and clinical chemistry tests on a single instrument, with potential for further molecular testing expansion.

Major companies operating in the immunoassay biomarker test menu expansion market are Tecan Trading AG, Euroimmun Medizinische Labordiagnostika AG, OPKO Health Inc. , Autobio Diagnostics Co. Ltd. , Promega Corporation, BioLegend Inc. , Sekisui Diagnostics LLC, Boditech Med Inc. , Dynex Technologies Inc. , QuantuMDx Group Ltd. , NanoEntek, J. Mitra & Co. Pvt. Ltd. , Baebies, ALPCO Diagnostics, Micropoint Bioscience, Coris BioConcept, MiCo BioMed Inc. , Kamiya Biomedical Company, Abionic SA, ANP Technologies Inc. , Axis-Biosciences / Axela, Epitope Diagnostics Inc. , MedMira Inc. , Nanomix Inc.

North America was the largest region in the immunoassay biomarker test menu expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoassay biomarker test menu expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunoassay biomarker test menu expansion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunoassay biomarker test menu expansion market consists of sales of enzyme-linked immunosorbent assay kits, chemiluminescent immunoassay kits, fluorescent immunoassay kits, multiplex immunoassay panels, rapid diagnostic test kits, biomarker-specific reagents, calibration standards, and quality control materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoassay Biomarker Test Menu Expansion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunoassay biomarker test menu expansion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoassay biomarker test menu expansion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunoassay biomarker test menu expansion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Enzyme-Linked Immunosorbent Assay Kits; Chemiluminescent Immunoassay Kits; Fluorescent Immunoassay Kits; Multiplex Immunoassay Panels; Rapid Diagnostic Test Kits; Biomarker-Specific Reagents; Calibration Standards; Quality Control Materials
2) By Biomarker Type: Oncology Biomarkers; Cardiac Biomarkers; Endocrine And Hormonal Biomarkers; Infectious Disease Biomarkers; Autoimmune Disease Biomarkers; Neurological Biomarkers; Therapeutic Drug Monitoring Biomarkers
3) By Grade: High-Performance Liquid Chromatography (HPLC) And Ultra-High-Performance Liquid Chromatography (UHPLC) Grade Reagents; Gas Chromatography (GC) Grade Reagents; Analytical Grade Reagents; Liquid Chromatography-Mass Spectrometry (LC-MS) Grade Reagents; Preparative Grade Reagents; Biotechnology Grade Reagents; Technical Grade Filtration Products
4) By Application: Clinical Diagnostics; Companion Diagnostics; Personalized Medicine; Drug Discovery And Clinical Research
5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Contract Manufacturing Organizations; Academic And Research Institutions; Clinical And Diagnostic Laboratories; Food And Beverage Testing Laboratories; Environmental Testing Laboratories; Government And Regulatory Agencies; Chemical And Industrial Manufacturing Companies
Subsegments:
1) By Enzyme-Linked Immunosorbent Assay Kits: Sandwich Assay Kits; Competitive Assay Kits; Indirect Assay Kits; Direct Assay Kits
2) By Chemiluminescent Immunoassay Kits: Magnetic Particle-Based Kits; Solid Phase Kits; Microplate-Based Kits; Automated Analyzer Kits
3) By Fluorescent Immunoassay Kits: Time-Resolved Fluorescence Kits; Lateral Flow Fluorescence Kits; Microbead-Based Kits; Multiplex Fluorescence Kits
4) By Multiplex Immunoassay Panels: Cytokine Panels; Cardiac Marker Panels; Oncology Panels; Infectious Disease Panels
5) By Rapid Diagnostic Test Kits: Lateral Flow Immunoassays; Colloidal Gold Test Kits; Microfluidic Rapid Kits; Paper-Based Diagnostic Kits
6) By Biomarker-Specific Reagents: Antibodies; Antigens; Conjugates; Detection Reagents
7) By Calibration Standards: Protein Standards; Peptide Standards; Whole Blood Controls; Serum Controls
8) By Quality Control Materials: Positive Controls; Negative Controls; Internal Controls; External Controls
Companies Mentioned: Tecan Trading AG; Euroimmun Medizinische Labordiagnostika AG; OPKO Health Inc.; Autobio Diagnostics Co. Ltd.; Promega Corporation; BioLegend Inc.; Sekisui Diagnostics LLC; Boditech Med Inc.; Dynex Technologies Inc.; QuantuMDx Group Ltd.; NanoEntek; J. Mitra & Co. Pvt. Ltd.; Baebies; ALPCO Diagnostics; Micropoint Bioscience; Coris BioConcept; MiCo BioMed Inc.; Kamiya Biomedical Company; Abionic SA; ANP Technologies Inc.; Axis-Biosciences / Axela; Epitope Diagnostics Inc.; MedMira Inc.; Nanomix Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: MC4MIEMF01_G26Q2

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Immunoassay Biomarker Test Menu Expansion Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Immunoassay Biomarker Test Menu Expansion Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Immunoassay Biomarker Test Menu Expansion Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Immunoassay Biomarker Test Menu Expansion Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Expansion Of Multiplex Immunoassay Panels For Multi Biomarker Disease Detection
- 4.2.2 Increasing Development Of High Sensitivity Chemiluminescent Immunoassay Platforms
- 4.2.3 Rising Adoption Of Personalized Medicine Driven Biomarker Testing Solutions
- 4.2.4 Growing Integration Of Automated Laboratory Immunoassay Analyzers For High Throughput Testing
- 4.2.5 Increasing Demand For Oncology And Infectious Disease Biomarker Assay Expansion

5. Immunoassay Biomarker Test Menu Expansion Market Analysis Of End Use Industries

5.1 Pharmaceutical And Biotechnology Companies
5.2 Contract Research Organizations
5.3 Clinical And Diagnostic Laboratories
5.4 Academic And Research Institutions
5.5 Other End Users

6. Immunoassay Biomarker Test Menu Expansion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunoassay Biomarker Test Menu Expansion Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Immunoassay Biomarker Test Menu Expansion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Immunoassay Biomarker Test Menu Expansion Market Size, Comparisons And Growth Rate Analysis
7.3. Global Immunoassay Biomarker Test Menu Expansion Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Immunoassay Biomarker Test Menu Expansion Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunoassay Biomarker Test Menu Expansion Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunoassay Biomarker Test Menu Expansion Market Segmentation

9.1. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Enzyme-Linked Immunosorbent Assay Kits, Chemiluminescent Immunoassay Kits, Fluorescent Immunoassay Kits, Multiplex Immunoassay Panels, Rapid Diagnostic Test Kits, Biomarker-Specific Reagents, Calibration Standards, Quality Control Materials
9.2. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology Biomarkers, Cardiac Biomarkers, Endocrine And Hormonal Biomarkers, Infectious Disease Biomarkers, Autoimmune Disease Biomarkers, Neurological Biomarkers, Therapeutic Drug Monitoring Biomarkers
9.3. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
High-Performance Liquid Chromatography (HPLC) And Ultra-High-Performance Liquid Chromatography (UHPLC) Grade Reagents, Gas Chromatography (GC) Grade Reagents, Analytical Grade Reagents, Liquid Chromatography-Mass Spectrometry (LC-MS) Grade Reagents, Preparative Grade Reagents, Biotechnology Grade Reagents, Technical Grade Filtration Products
9.4. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Clinical Diagnostics, Companion Diagnostics, Personalized Medicine, Drug Discovery And Clinical Research
9.5. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Contract Manufacturing Organizations, Academic And Research Institutions, Clinical And Diagnostic Laboratories, Food And Beverage Testing Laboratories, Environmental Testing Laboratories, Government And Regulatory Agencies, Chemical And Industrial Manufacturing Companies
9.6. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Sandwich Assay Kits, Competitive Assay Kits, Indirect Assay Kits, Direct Assay Kits
9.7. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Chemiluminescent Immunoassay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Magnetic Particle-Based Kits, Solid Phase Kits, Microplate-Based Kits, Automated Analyzer Kits
9.8. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Fluorescent Immunoassay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Time-Resolved Fluorescence Kits, Lateral Flow Fluorescence Kits, Microbead-Based Kits, Multiplex Fluorescence Kits
9.9. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Multiplex Immunoassay Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cytokine Panels, Cardiac Marker Panels, Oncology Panels, Infectious Disease Panels
9.10. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Rapid Diagnostic Test Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lateral Flow Immunoassays, Colloidal Gold Test Kits, Microfluidic Rapid Kits, Paper-Based Diagnostic Kits
9.11. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Biomarker-Specific Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Antibodies, Antigens, Conjugates, Detection Reagents
9.12. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Calibration Standards, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Protein Standards, Peptide Standards, Whole Blood Controls, Serum Controls
9.13. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Quality Control Materials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Positive Controls, Negative Controls, Internal Controls, External Controls

10. Immunoassay Biomarker Test Menu Expansion Market Regional And Country Analysis

10.1. Global Immunoassay Biomarker Test Menu Expansion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Immunoassay Biomarker Test Menu Expansion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunoassay Biomarker Test Menu Expansion Market

11.1. Asia-Pacific Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunoassay Biomarker Test Menu Expansion Market

12.1. China Immunoassay Biomarker Test Menu Expansion Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunoassay Biomarker Test Menu Expansion Market

13.1. India Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunoassay Biomarker Test Menu Expansion Market

14.1. Japan Immunoassay Biomarker Test Menu Expansion Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunoassay Biomarker Test Menu Expansion Market

15.1. Australia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunoassay Biomarker Test Menu Expansion Market

16.1. Indonesia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunoassay Biomarker Test Menu Expansion Market

17.1. South Korea Immunoassay Biomarker Test Menu Expansion Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunoassay Biomarker Test Menu Expansion Market

18.1. Taiwan Immunoassay Biomarker Test Menu Expansion Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunoassay Biomarker Test Menu Expansion Market

19.1. South East Asia Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunoassay Biomarker Test Menu Expansion Market

20.1. Western Europe Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunoassay Biomarker Test Menu Expansion Market

21.1. UK Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunoassay Biomarker Test Menu Expansion Market

22.1. Germany Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunoassay Biomarker Test Menu Expansion Market

23.1. France Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunoassay Biomarker Test Menu Expansion Market

24.1. Italy Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunoassay Biomarker Test Menu Expansion Market

25.1. Spain Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunoassay Biomarker Test Menu Expansion Market

26.1. Eastern Europe Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunoassay Biomarker Test Menu Expansion Market

27.1. Russia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunoassay Biomarker Test Menu Expansion Market

28.1. North America Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunoassay Biomarker Test Menu Expansion Market

29.1. USA Immunoassay Biomarker Test Menu Expansion Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunoassay Biomarker Test Menu Expansion Market

30.1. Canada Immunoassay Biomarker Test Menu Expansion Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunoassay Biomarker Test Menu Expansion Market

31.1. South America Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunoassay Biomarker Test Menu Expansion Market

32.1. Brazil Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunoassay Biomarker Test Menu Expansion Market

33.1. Middle East Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunoassay Biomarker Test Menu Expansion Market

34.1. Africa Immunoassay Biomarker Test Menu Expansion Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunoassay Biomarker Test Menu Expansion Market Regulatory and Investment Landscape

36. Immunoassay Biomarker Test Menu Expansion Market Competitive Landscape And Company Profiles

36.1. Immunoassay Biomarker Test Menu Expansion Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Immunoassay Biomarker Test Menu Expansion Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Immunoassay Biomarker Test Menu Expansion Market Company Profiles
- 36.3.1. Tecan Trading AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Euroimmun Medizinische Labordiagnostika AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. OPKO Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Autobio Diagnostics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Promega Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Immunoassay Biomarker Test Menu Expansion Market Other Major And Innovative Companies

BioLegend Inc., Sekisui Diagnostics LLC, Boditech Med Inc., Dynex Technologies Inc., QuantuMDx Group Ltd., NanoEntek, J. Mitra & Co. Pvt. Ltd., Baebies, ALPCO Diagnostics, Micropoint Bioscience, Coris BioConcept, MiCo BioMed Inc., Kamiya Biomedical Company, Abionic SA, ANP Technologies Inc.

38. Global Immunoassay Biomarker Test Menu Expansion Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Immunoassay Biomarker Test Menu Expansion Market

41. Immunoassay Biomarker Test Menu Expansion Market High Potential Countries, Segments and Strategies

41.1 Immunoassay Biomarker Test Menu Expansion Market In 2030 - Countries Offering Most New Opportunities
41.2 Immunoassay Biomarker Test Menu Expansion Market In 2030 - Segments Offering Most New Opportunities
41.3 Immunoassay Biomarker Test Menu Expansion Market In 2030 - Growth Strategies
- 41.3.1 Market Trend Based Strategies
- 41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer